microdosing glp 1 autoimmune Can Microdose GLP-1 Agonists Help Disease? GLP-1 Medications and Rheumatoid Arthritis:

California joined New Hampshire, Pennsylvania and South Carolina in ending coverage for adult obesity treatment, while other states are planning or considering restrictions

To a similar end, Endocrine News focuses on a few recent journal studies that take a closer look at the impacts of incretin-based therapies in the setting of obesity and impaired cardiovascular health, as well as how they affect the liver, quality of life, insulin resistance, and much more

however, delayed gastric emptying, called gastroparesis, and increased colonic transit time are common side effects of these medications that raise concerns about the possibility of aspiration pneumonia following endoscopy

Researcher audience framing

The dose-response network meta-analysis showed that increasing doses of GLP-1 RAs heightened the risk of nausea, vomiting, diarrhea, constipation, and decreased appetite